Banaszek, Natalia
Kurpiewska, Dominika
Kozak, Katarzyna http://orcid.org/0000-0002-3225-422X
Rutkowski, Piotr http://orcid.org/0000-0002-8920-5429
Sobczuk, Paweł http://orcid.org/0000-0002-4103-1626
Article History
Received: 27 July 2023
Accepted: 20 September 2023
First Online: 10 October 2023
Declarations
:
: Pawel Sobczuk has received travel grants from MSD, BMS, Roche, Novartis, and Pierre Fabre; honoraria for lectures from Swixx BioPharma, BMS, Gilead and Sandoz; honoraria for Advisory Boards from Sandoz; is a stock owner of Celon Pharma; Non-financial interests: European Society of Medical Oncology—Officer; Polish Society of Clinical Oncology—Member of Board of Directors. Katarzyna Kozak has received honoraria for lectures and travel grants from BMS, MSD, Novartis, Pfizer, and Pierre Fabre. Piotr Rutkowski has received honoraria for lectures from BMS, Merck, MSD, Novartis, Pierre Fabre, Sanofi; honoraria for Advisory Boards from Blueprint Medicines, BMS, Merck, MSD, Novartis, Pierre Fabre, Sanofi; Institutional funding support from BMS and Pfizer; Non-financial interests: ASCO—Officer, Polish Society of Surgical Oncology—Member of Board of Directors, Polish Oncological Society—President. Natalia Banaszek and Dominika Kurpiewska declare no conflict of interest.
: Not applicable.